Source fact
us-gaap:Revenues
0000014272-26-000020
Health Care · BMY
Bristol Myers Squibb
Reported results, filing history, and direct access to the source documents.
LATEST QUARTERLY REPORT
10-Q · Period ended 2026-06-30
Filed 2026-07-30. Values below belong to this filing, not a rolling twelve-month estimate. Duration figures may cover a full year or year-to-date period.
Source fact
us-gaap:NetIncomeLoss
0000014272-26-000020
Source fact
us-gaap:Assets
0000014272-26-000020
Source fact
us-gaap:NetCashProvidedByUsedInOperatingActivities
0000014272-26-000020
LATEST ANNUAL REPORT
10-K · Period ended 2025-12-31
Filed 2026-02-11. Values below belong to this filing, not a rolling twelve-month estimate. Duration figures may cover a full year or year-to-date period.
Source fact
us-gaap:Revenues
0000014272-26-000004
Source fact
us-gaap:NetIncomeLoss
0000014272-26-000004
Source fact
us-gaap:Assets
0000014272-26-000004
Source fact
us-gaap:NetCashProvidedByUsedInOperatingActivities
0000014272-26-000004
Disclosure timeline
Latest tracked 10-K, 10-Q, amendments, and earnings-related 8-K Item 2.02 filings. Amendments are listed but do not automatically replace the original report's facts.
10-Q · Period ended 2026-06-30 →Accession 0000014272-26-000020
8-K · Results of operations disclosure →Accession 0000014272-26-000018
10-Q · Period ended 2026-03-31 →Accession 0000014272-26-000010
8-K · Results of operations disclosure →Accession 0000014272-26-000008
10-K · Period ended 2025-12-31 →Accession 0000014272-26-000004
8-K · Results of operations disclosure →Accession 0000014272-26-000002
10-Q · Period ended 2025-09-30 →Accession 0000014272-25-000149
8-K · Results of operations disclosure →Accession 0000014272-25-000147
10-Q · Period ended 2025-06-30 →Accession 0000014272-25-000131
8-K · Results of operations disclosure →Accession 0000014272-25-000129
10-Q · Period ended 2025-03-31 →Accession 0000014272-25-000091
8-K · Results of operations disclosure →Accession 0000014272-25-000089
10-K · Period ended 2024-12-31 →Accession 0000014272-25-000039
8-K · Results of operations disclosure →Accession 0000014272-25-000037
10-Q · Period ended 2024-09-30 →Accession 0000014272-24-000147
8-K · Results of operations disclosure →Accession 0000014272-24-000145
10-Q · Period ended 2024-06-30 →Accession 0000014272-24-000123
8-K · Results of operations disclosure →Accession 0000014272-24-000121
10-Q · Period ended 2024-03-31 →Accession 0000014272-24-000096
8-K · Results of operations disclosure →Accession 0000014272-24-000094
10-K · Period ended 2023-12-31 →Accession 0000014272-24-000044
8-K · Results of operations disclosure →Accession 0000014272-24-000020
10-Q · Period ended 2023-09-30 →Accession 0000014272-23-000181
8-K · Results of operations disclosure →Accession 0000014272-23-000179
Read with context.
These are automatically extracted filing facts, not a complete financial review. Different companies and report types may use different reporting periods and accounting definitions. Missing values are not zero. No stock prices, earnings forecasts, or buy/sell ratings are provided.
All SEC filings for this company · Sources, coverage, and methodology
For education and research only. Not investment advice. Verify original filings before making decisions.